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DNA methylation and demethylation have been
proposed to play an important role in somatic cell re-
programming. Here, we demonstrate that the DNA
hydroxylase Tet1 facilitates pluripotent stem cell
induction by promoting Oct4 demethylation and re-
activation. Moreover, Tet1 (T) can replace Oct4 and
initiate somatic cell reprogramming in conjunction
with Sox2 (S), Klf4 (K), and c-Myc (M).We established
an efficient TSKM secondary reprogramming system
and used it to characterize the dynamic profiles of
5-methylcytosine (5mC), 5-hydroxymethylcytosine
(5hmC), and gene expression during reprogramming.
Our analysis revealed that both 5mC and 5hmC
modifications increased at an intermediate stage of
the process, correlating with a transition in the tran-
scriptional profile. We also found that 5hmC enrich-
ment is involved in the demethylation and reactiva-
tion of genes and regulatory regions that are
important for pluripotency. Our data indicate that
changes in DNA methylation and hydroxymethyla-
tion play important roles in genome-wide epigenetic
remodeling during reprogramming.
INTRODUCTION
The direct reprogramming of differentiated somatic cells to
induced pluripotent stem cells (iPSCs) can be achieved through
the overexpression of a set of defined transcription factors such
as Oct4 (O), Sox2 (S), Klf4 (K), and c-Myc (M) (Maherali et al.,
2007; Okita et al., 2007; Takahashi et al., 2007; Takahashi and
Yamanaka, 2006; Wernig et al., 2007). The full pluripotency of
iPSCs has been confirmed by the production of viable all-iPSC
mice through tetraploid complementation (Boland et al., 2009;
Kang et al., 2009; Zhao et al., 2009).
Global epigenetic reprogramming of DNA and histones is
crucial for the reprogramming process overall and involves theremoval of the original somatic cell epigenetic landscape and
the establishment of a pluripotent stem cell-specific epigenetic
landscape in its place. Many regulators of chromatin modifica-
tion play important roles in reprogramming to iPSCs (Onder
et al., 2012; Singhal et al., 2010; Surani et al., 2007; Wang
et al., 2011; Yang et al., 2011), and inhibitors of histone deacety-
lases or DNA methylation have also been useful in improving re-
programming efficiency (Plath and Lowry, 2011). Uncovering the
molecular mechanisms involved may lead to improvements in
both reprogramming efficiency and iPSC quality, and thus ulti-
mately advance therapeutic application.
The generation of iPSCs can be affected significantly by
the initial expression of reprogramming factors, starting cell
types, and induction methods. Through the development of
a secondary (2) reprogramming system, iPSC generation was
initially described as a multistep process characterized by
phenotypic, transcriptional, and chromatin changes (Plath and
Lowry, 2011). More recently, genome-wide analysis of specific
chromatin modification dynamics (gain of H3K4me2) at early
stages of reprogramming indicated that this progress might be
constrained by repressive epigenetic modifications, such as
H3K9me3 and DNA methylation (Koche et al., 2011; Soufi
et al., 2012). H3K9me3 and DNA methylation are considered
major barriers to faithful reprogramming (Chen et al., 2013;
Meissner et al., 2008).
It has been proposed that DNA methylation functions in the
silencing of somatic genes and chromatin remodeling during
iPSC generation (Plath and Lowry, 2011), and DNA demethyla-
tion appears to play an important role in reactivating pluripotency
genes, which are hypermethylated and silenced in somatic cells,
particularly in the late stages of the reprogramming process
(Mikkelsen et al., 2008). Recently, 5-hydroxymethylcytosine
(5hmC), formed by hydroxylation of 5-methylcytosine (5mC) by
Tet1–Tet3 proteins, has been detected in a broad range of cell
types and is thought to be involved in active and/or passive
DNA demethylation (Tahiliani et al., 2009; Wu and Zhang,
2011). Two recent studies have shown that some of the erasure
of CpG methylation during primordial germ cell (PGC) speci-
fication occurs via 5mC-to-5hmC conversion driven by Tet1
and Tet2 (Hackett et al., 2013; Vincent et al., 2013). In addition,
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et al., 2012). However, overall understanding of the global
dynamics of DNA modification and the molecular mechanisms
for DNA demethylation during reprogramming remains poor.
In the present study, we show that Tet1 acts at the Oct4 loci
to promote 5mC-to-5hmC conversion and facilitates the DNA
demethylation and transcriptional reactivation during OSKM
iPSC induction. Importantly, we found that Tet1 can replace
Oct4 in the initiation of reprogramming in combination with
SKM. We established an efficient TSKM 2 reprogramming
system, which was used to identify an intermediate stage in
the reprogramming process and to dissect the molecular events
involved. Overall, we characterized a unique DNA methylation
and hydroxymethylation state map, and our data further suggest
that 5mC-to-5hmC conversion represents a crucial step in the
initiation of epigenetic remodeling and transcriptome resetting
to achieve a pluripotent state.
RESULTS
Tet1 Can Facilitate Traditional iPSC Induction in
a Hydroxylase-Dependent Manner
To investigate the role of DNA methylation and demethylation
during reprogramming, we focused on the Tet family proteins,
which have been proposed to play important roles in initiating
DNA demethylation through 5mC oxidation (Wu and Zhang,
2011). We first examined the expression dynamics of Tet1–
Tet3 during reprogramming and in iPSCs. Consistent with
previous reports (Koh et al., 2011; Polo et al., 2012), Tet1 was
more significantly upregulated than Tet2 in iPSCs, whereas
Tet3 was repressed (Figure 1A). Although Tet2 was upregulated
as early as day 3 in OSKM-induced reprogramming, only Tet1
showed a progressive upregulation in both OSKM- and OSK-
induced reprogramming systems (Figure 1B; Figure S1A avail-
able online). We further demonstrated that the formation of
iPSC colonies was abolished by short hairpin RNA (shRNA)-
mediated Tet1 knockdown (Tet1kd) in both the OSKM and
OSK (4F and 3F) induction systems (Figure 1C).
To further explore the potential function of Tet1 in reprogram-
ming, we performed both gain- and loss-of-function studies (Fig-
ure 1D). We used lentiviral-based doxycycline (Dox)-inducible
expression vectors to exogenously express genes. The OSKM
and OSK primary induction system (fibroblasts with the Oct4-Figure 1. Tet1 Can Facilitate Traditional iPSC Induction
(A) Tet1 is highly expressed in pluripotent stem cells. The expression levels of the
and compared via fold changes from differentiated cells to pluripotent cells (MEF
(B) Tet1 is progressively upregulated in OSK iPSC induction. qRT-PCR analyses o
respectively.
(C) Tet1 deficiency reduces the alkaline phosphatase (AP)-positive colonies in iPS
induction, respectively.
(D) Strategy for functional studies of Tet1 in reprogramming. Parallel experimen
Tet1 (Tm), shRNA for Tet1 (Tet1kd-1 and Tet1kd-2) and RFP control (Ctr). rtTA, r
(E) Expression of Tet1, but not Td, facilitates the formation of Oct4-GFP+ colonies
10–14 in OSK (right) after Dox induction.
(F) The percentage of Oct4-GFP+ cells is increased by Tet1. FACS analysis was p
(right) at day 14.
(G and H) Kinetics of the AP+ colony formation are facilitated by Tet1 and abolish
colonies was counted and compared with the control in (G). Representative AP-
Data in (A)–(C) are represented as the mean ± SD (n = 3). Data in E–G are represen
0.001 by ANOVA or Student’s t test for comparison. See also Figure S1.GFP/Rosa26-M2rtTA background) was used for first verifying
whether Tet1 could increase reprogramming efficiency. We
found that the formation of Oct4-GFP+ colonies was promoted
markedly by ectopic expression of Tet1 in both the OSKM and
OSK induction systems (Figures 1E and S1B–S1D). The
percentage of Oct4-GFP+ cells also increased (Figures 1F and
S1E). Importantly, the catalytic domain (CD) of Tet1 appeared
to be essential for its function in this context, because ectopic
expression of CD-deleted Tet1 (Td) did not have a positive effect
on reprogramming (Figures 1E, 1F, and S1B–S1E).
For ruling out the possible influence of variation in transgene
expression, an OSKM 2 reprogramming system established in
our lab was used for further studies (Kang et al., 2009; Kou
et al., 2010). We optimized the expression of exogenous Tet1
(Figures S1F and S1G) and constructed a mutant Tet1 (Tm)
that is full length but lacks DNA hydroxylase activity (Figures
S1B and S1C). OSKM 2 fibroblasts were infected with similar
amounts of Tet1, Td, Tm, control, or Tet1-shRNA viruses and
were then induced by Dox under the same culture conditions
(Figure 1D). Total Tet1 expression levels were confirmed using
primers on the CD on induction day 3 (Figure S1H).
The percentage of SSEA1+ cells (as determined using fluores-
cence-activated cell sorting [FACS] analysis) and the number of
AP+ colonies were used for measuring the kinetics and the effi-
ciency of reprogramming, respectively. We found that when
Tet1 was repressed by shRNA, the increase in SSEA1+ cells
was delayed, and colony formation was abolished (Figures 1G,
1H, S1I, and S1J). In contrast, ectopic expression of wild-type
Tet1 accelerated the reprogramming process and increased
the efficiency significantly. Although the overexpression of Td
and Tm also promoted the expression of SSEA1 (Figures S1I
and S1J), the number of AP+ colonies showed no significant
differences compared with the control (Figures 1G and 1H).
Taken together, these results demonstrate that Tet1 facilitates
OSKM-mediated iPSC induction in a hydroxylase-activity-
dependent manner.
Tet1 and 5hmC Involve Demethylation of the Oct4
Enhancer and Promoter during OSKM Reprogramming
The demethylation and reactivation of Oct4 is a crucial step in
reprogramming (Plath and Lowry, 2011). We examined Oct4
expression levels in SSEA1+ cells sorted on induction day 11
and found that only wild-type Tet1, but not Td or Tm, promotedTets were normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh)
versus R1 ESC, and OSKM 0D versus OSKM iPSC).
f Tet1 and Tet2 expression were normalized toGapdh and compared withMEF,
C induction. AP staining was performed at day 12 and day 16 in OSKMandOSK
ts were performed using wild-type Tet1 (Tet1), truncated Tet1 (Td), mutated
everse tetracycline transactivator; ESM, ESC culture media.
. The Oct4-GFP+ colonies were counted on days 10–13 in OSKM (left) and days
erformed by the end of primary iPSC induction: OSKM (left) at day 13 and OSK
ed by Tet1kds from day 5 to day 11 in OSKM 2 induction. The number of AP+
stained plates during reprogramming are shown in (H).
ted as the mean ± SEM (n = 3 in E and F; n = 2 in G). *p < 0.05; **p < 0.01; ***p <
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Figure 2. Tet1 Can Reactivate Oct4 during OSKM Reprogramming
(A) Diagram of the analyzed regions ofOct4. The reported T-DMRs and Tet1-targeted regions in ESCs, as well as the number of CpGdinucleotides inBfaI-defined
regions, are labeled. The enhancer (S3&4, DE) and promoter (F2, PR) were identified as R-DMRs of Oct4.
(B) CpG dinucleotides of Oct4 R-DMRs were demethylated through OSKM induction. Bisulfite sequencing analysis was performed on differentiated cells and
pluripotent cells (OG2MEF versus R1 ESC andOSKM 0D versus OSKM iPSC). The open circles indicate unmethylated CpG dinucleotides, and the closed circles
indicate methylated CpG dinucleotides.
(C and E) Time course of relative 5mC/5hmC enrichment at Oct4 enhancer (C) and promoter (E) during OSKM 2 induction.
(D and F) Time course of Tet1–Tet3 occupancy at Oct4 enhancer (D) and promoter (F) during OSKM 2 induction.
(legend continued on next page)
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lated by the CpG methylation levels of tissue-dependent, differ-
entially methylated regions (T-DMRs) (Hattori et al., 2004), and
Oct4 can be targeted directly by Tet1 in embryonic stem cells
(ESCs) (Wu et al., 2011). Therefore, we next examined whether
Tet1 and 5hmC are involved inOct4 demethylation and reactiva-
tion during OSKM reprogramming.
We identified two reprogramming-related, differentially meth-
ylated regions (R-DMRs) in the Oct4 gene (including enhancer
and promoter regions) that undergo DNA demethylation during
reprogramming (Figures 2A and 2B). We used methylated or
hydroxymethylated DNA immunoprecipitation quantitative PCR
(MeDIP or hMeDIP qPCR) to track the dynamics of the relative
5mC or 5hmC levels, respectively, at Oct4 R-DMRs from induc-
tion day 1 to day 7 in theOSKM2 system.We also quantified the
total cytosine methylation level (5mC plus 5hmC) through bisul-
fite sequencing analysis of the same regions.
We found that 5hmC enrichment increased in parallel with
a decrease in 5mC at these loci from day 1 to day 5 of the reprog-
ramming process (Figures 2C and 2E). In addition, chromatin
immunoprecipitation (ChIP) demonstrated that the occupancy
of Tet proteins at these two loci was different (Figures 2D and
2F). The binding of Tet1, but not Tet2 or Tet3, was increased
from day 1 to day 5, which coincided perfectly with the 5hmC
increase (Figures 2C–2F). These results suggest that Tet1 and
5hmC may function since the early stage of reprogramming
and might be directly involved in the DNA demethylation of
Oct4 R-DMRs.
Unexpectedly, we noticed an increase in 5mC levels at Oct4
R-DMRs at day 1 of OSKM-mediated reprogramming (Figures
2C and 2E). We performed bisulfite analyses (Gruntman et al.,
2008) to quantify the methylated cytosine levels during reprog-
ramming and their dynamics on CG, CHG (H = C/A/T), and CHH
(H = C/A/T) sites. We found that the major demethylation events
in these two regions took place at a relatively late stage on CG
sites (from day 5) in reprogramming, whereas de novo non-CpG
DNA methylation occurred primarily on CHG and CHH sites,
potentially explaining the observed increase in 5mC (Figure S2B).
This finding is also consistent with previous data indicating that
DNA demethylation at the Oct4 gene occurs at a late stage in re-
programming (Mikkelsen et al., 2008; Polo et al., 2012).
Tet1 PromotesOct4Demethylation and Reactivation via
5hmC Conversion during OSKM Reprogramming
We next explored the role of Tet1 and 5hmC inOct4 reactivation
using established gain- and loss-of-function systems (Figure 1D).
The molecular changes at the Oct4 R-DMRs were analyzed and(G and H) DNAmodification changes atOct4 enhancer (G) and promoter (H) at ind
content of modified cytosine (right) of different conditions are presented.
(I and J) Tet1 can promote CpG demethylation at Oct4 enhancer (I) and promote
(K and L) Tet1 can promote the reactivation of Oct4 during OSKM 2 induction. Th
(M) Occupancy of H3K27me3, H3K4me3, and H3K4me2 at Oct4 enhancer (left)
(N) The CpG demethylation at the Oct4 enhancer and promoter is incomplete in
Gene expression was assessed by qRT-PCR, normalized by Actb, and compare
was determined by bisulfite sequencing and further analyzed on CGs, CHGs, an
hMeDIP-qPCR, respectively, relative to input (1/40) DNA. Occupancy of Tet1–Tet
10) and normalized by Actb. The cells for each kind of analysis during reprogram
Dox induction. Data in (C)–(H) and (K)–(M) are represented as the mean ± SD (n =
0.05; **p < 0.01; ***p < 0.001 by ANOVA or Student’s t test for comparison. Seecompared to Tet1 overexpression or repression during OSKM 2
reprogramming.
When compared to control OSKM-mediated reprogramming
(OSKM+Ctr) at day 1, overexpression of Tet1, but not Tm, led
to a significant and consistent increase in 5hmC and a corre-
sponding decrease in 5mC at both loci after 24 hr of Dox induc-
tion, whereas the total amount of modified cytosine was compa-
rable (Figures 2G and 2H). By contrast, Tet1kd by shRNA
resulted in an increase in 5mC and a decrease in 5hmC at these
two loci (Figures 2G and 2H). These results suggest that Tet1
expression converts 5mC to 5hmC at both the Oct4 enhancer
and promoter at the very beginning of reprogramming.
Importantly, overexpression of Tet1 also significantly
promoted the CpG demethylation process at both regions
(Figures 2I and 2J) and facilitated Oct4 transcriptional reactiva-
tion as early as day 3 (Figures 2K and 2L). Interestingly, we
noticed that Tet1 expression limited the increase in total 5mC
at early stages (Figures S2C and S2D). However, Tet1 deficiency
impeded the increase in 5hmC during the entire process and led
to a more significant increase in 5mC on day 1 at both loci
(Figures S2C and S2D). These results suggest that the function
of Tet1 may not be limited to the CpG sites. ChIP analysis on
day 3 also revealed a significant enrichment of activation-asso-
ciated histone modifications, including H3K4me3 and
H3K4me2, but not the repressive mark H3K27me3, at the two
loci when Tet1 was overexpressed (Figure 2M).
After day 1, the changes in 5hmC and Tet binding at both loci
became more complicated. For example, compared with the
control, H3K4me3 and H3K27me3 were enriched at the Oct4
promoter, but not the enhancer, in OSKM+Tet1kd day 3 cells.
ChIP analysis further revealed increased occupancy of Tet1
and Tet3 (but not Tet2) at the Oct4 promoter, whereas the
binding of all Tets at the Oct4 enhancer was comparable to
the OSKM+Ctr cells on day 3 (Figures S2E and S2F). Overall,
though, Oct4 demethylation and reactivation were repressed
by Tet1kd on day 3 (Figures 2I, 2J, and 2L).
Although redundant binding of Tets might occur, Tet1 expres-
sion during reprogramming appears to be more significant for
Oct4 reactivation. It is interesting that even in the Tet1-deficient
primary OSKM reprogramming, some Dox-independent AP+
iPSC lines were established, but they had a low Oct4-GFP signal
(Figure S2G). Oct4 demethylation and reactivation were incom-
plete in these Tet1-deficient iPSC lines (4F-Tet1kd iPSC a and
b) compared to ESCs and Tet1-deficient ESCs, even though
Sox2 expression (demethylation independent) was reactivated
normally, and Tet2 and Tet3 were also highly expressed in one
of the lines (4F-Tet1kd-b) (Figures 2N and S2H).uction day 1 in the OSKM 2 system. Relative 5mC/5hmC enrichment (left) and
r (J) during OSKM 2 induction.
e time course is compared in (K), and the comparison on day 3 is shown in (L).
and promoter (right) in cultures as indicated.
two OSKM-Tet1kd iPSC lines, as compared with R1 ESCs.
d to those observed in R1 ESCs. Content of modified cytosines (5hmC+5mC)
d CHHs. The relative 5mC and 5hmC levels were determined by MeDIP- and
3 and the histone markers was determined by ChIP-qPCR, relative to input (1/
ming were collected from the same or parallel culture plates every 2 days after
3). Data in (I), (J), and (N) are represented as the mean ± SEM (n = 1016). *p <
also Figure S2.
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demethylation and reactivation through 5mC-to-5hmC conver-
sion at a very early stage in OSKM-mediated reprogramming.
Tet1 Can Replace Oct4 in the Induction of
Reprogramming
After establishing that Tet1 promotes Oct4 reactivation early in
reprogramming,wenext investigatedwhether Tet1 could replace
Oct4 during iPSC induction. To this end, we infected mouse
embryonic fibroblasts (MEFs) (Oct4-GFP/Rosa26-M2rtTA) with
viruses expressing Tet1, Sox2, Klf4, and c-Myc (TSKM) using
a traditional infectionmethod (Figures 3A and S3A). Interestingly,
we observed Oct4-GFP+ colonies (68 ± 12 per 100,000 MEFs
plated) within 3–4 weeks of induction, and FACS analysis re-
vealed that 6.6% of the cells were Oct4-GFP+ by the end of the
reprogramming process (Figures 3B and 3C). By contrast, we
saw no Oct4-GFP+ colonies or cells from MEFs infected with
SKM+Td, SKM+Tm, or SKM+Ctr combinations under the same
conditions. We also found that c-Myc was dispensable for re-
programming with this approach (Figure 3B), and that other cell
types such as trophoblast stem cells (TSCs) could be reprog-
rammed successfully using TSKM (Figure S3B).
TSKM-Reprogrammed iPSCs Are Fully Pluripotent
We selected and propagated Oct4-GFP+ colonies without Dox
to generate TSKM iPSC lines and characterized their pluripo-
tency further. One representative cell line, TSKM-iPS8 (40 chro-
mosomes, XY; Figure S3C), was analyzed with regard to tran-
scription, epigenetic modification, and developmental
potential. The reported fully pluripotent 4F iPSCs and 3F iPSCs
(Kang et al., 2009; Kang et al., 2011) and the R1 ESCs were
used as controls.
In TSKM-iPS8 cells, the exogenous vectors were silenced
(Figure S3D), and pluripotency-marker expression was the
same as that seen in fully pluripotent 4F iPSCs and 3F iPSCs
and in R1 ESCs (Figures 3D, 3E, and S3E). The global gene-
expression profiles of TSKM-iPS8 cells resembled R1 ESCs
but were distinct from those of somatic fibroblasts (Figures 3G
and S3F). Bisulfite sequencing analysis indicated that successful
demethylation occurred at the promoters of Oct4 and Nanog
during TSKM reprogramming (Figure 3F).
TSKM-iPS8 cells also showed development potential both
in vitro and in vivo. Embryoid bodies (EBs) were formed usingFigure 3. Tet1 Can Replace Oct4 and Generate Fully Pluripotent iPSCs
(A) Strategy for generating TSKM iPSCs.
(B) Morphology of Oct4-GFP+ TSKM and TSK iPSC colonies.
(C) Only wild-type Tet1 can generate Oct4-GFP+ cells in combination with S
combinations. Data are represented as the mean ± SEM (n = 3).
(D) qRT-PCR analysis of pluripotency genes expression in TSKM iPSCs and 4F-
levels were normalized to those observed in R1 ESCs and represented as mean
(E) Immunofluorescent staining of pluripotency markers in TSKM iPSCs. Scale b
(F) The Oct4 and Nanog promoter regions in MEFs undergo demethylation in TS
sequencing. Open and closed circles indicate the unmethylated and methylated
(G) Scatter-plot analysis comparison of the gene-expression profiles in TSKM iP
(H) TSKM iPS8 can generate full-term TSKM-iPSCmice through tetraploid comple
sequence length polymorphism analysis (lower row) of the TSKM-iPSC mice wer
and ICR mice were used as a negative control.
(I) Three adult TSKM-iPSC mice with germline transmission ability. The left mous
See also Figure S3.TSKM-iPS8 cells, and marker genes for the three germ layers
were detected in the plated EBs (Figures S3G and S3H). Tera-
tomas with three germ layers and chimeric mice with germline
transmission could be generated by TSKM-iPS8 cells (Figures
S3I and S3J).
Strikingly, through tetraploid complementation, we success-
fully obtained full-term, all-iPSC mice from this TSKM iPSC
line, which we referred to as TSKM mice. We produced 20 living
TSKM all-iPSC mice through Caesarean-section (C-section)
deliveries at embryonic day 19.5 (E19.5) (Figure 3H). We used
some of these full-term TSKM mice to derive somatic cells for
a 2 induction system. Three of the remaining TSKM mice
reached adulthood and were fertile (Figure 3I). Most strikingly,
we found that, thus far, all TSKMmice have been free of tumors,
unlike the OSKMmice (Figure S3K), and the oldest TSKMmouse
is now 2 years old.
These results demonstrate that fully reprogrammed iPSCs can
be obtained via TSKM-mediated reprogramming.
ATSKM2 Reprogramming SystemCan Initiate Efficient
Reprogramming
We established a secondary reprogramming system, referred to
as the TSKM 2 system, using fibroblasts derived from full-term,
TSKM mice (Figure 4A). After the addition of Dox, ectopic
expression of exogenous factors was detected (Figure S4A).
We analyzed the reprogramming process in the TSKM 2 system
using FACS analysis every 2 days. During TSKM 2 reprogram-
ming, the fibroblasts morphed into smaller, round cells at day 3
when SSEA1+ cells appeared; cell death was observed later,
and some cells clustered at approximately day 5. Oct4-GFP+
colonies appeared at day 7, and we analyzed the efficiency at
these points (Figures 4B and S4B–S4E). Interestingly, we found
that the percentage of double-positive cells (Oct4-GFP+,
SSEA1+) within the SSEA1+ population was much higher in the
TSKM 2 induction system than with OSKM (Figure S4F). Subse-
quently, we generated TSKM 2 iPSC lines (TSKM 2-iPSC) (Fig-
ure 4C), which also possessed full pluripotency and the ability to
generate full-term, all-iPSC mice (TSKM 2-iPSC mice;
Figure 4D).
These results indicate that faithful somatic cell reprogramming
can be achieved efficiently in the TSKM 2 reprogramming
system and that it provides a useful tool to further explore the
molecular dynamics of TSKM-mediated reprogramming.KM. FACS was performed at induction day 28 after infection with different
/3F-iPSCs. Both 4F- and 3F-iPSCs can produce all-iPS mice. The expression
± SD (n = 3).
ars represent 20 mm.
KM iPSCs, similar to that in R1 ESCs and 4F iPSCs as analyzed by bisulfite
CpGs, respectively.
SCs, fibroblasts, and R1 ESCs.
mentation. The newbornmicewere alive after C-section (upper row) and simple
e performed. TSKM iPSCs and C57BL/6J mice were used as positive controls
e is 2 years old, and the other two mice are 6 months old.
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during TSKM Reprogramming
To examine the role of Tet1 in TSKM-mediated programming, we
used gain- and loss-of-function analysis in the TSKM 2 system.
As in the OSKM system (Figures 1G, 1H, 2K, S1I, and S1J), Tet1
deficiency (Tet1 shRNA) in the TSKM 2 system delayed the
production of SSEA1+ and Oct4-GFP+ cells, and colony forma-
tion and Oct4 reactivation were abolished (Figures 4E, 4F, and
S4G–S4I). Although Tm and Td can facilitate the expression of
SSEA1, only wild-type Tet1 greatly promoted the generation of
Oct4-GFP+ cells, further improved colony formation, and facili-
tated Oct4 reactivation. The entire reprogramming process
was shortened by 2 days with additional Tet1 expression
(Figures S4G–S4I).
We also performed a side-by-side analysis of Oct4 reactiva-
tion in the TSKM 2 system. As in OSKM-mediated reprogram-
ming (Figure 2B), the Oct4 R-DMRs underwent demethylation
during TSKM-mediated reprogramming (Figure 4G). Compared
with OSKM reprogramming (Figures 2C, 2E, and S2B), we
observed a consistent increase in 5hmC in the TSKM 2 system,
but we no longer saw the sharp increase in 5mC on day 1 (Fig-
ure 4H). Bisulfite sequencing analysis further revealed that de
novo non-CpGmethylation was repressed during TSKM reprog-
ramming (Figure S4J).
Comparedwith the control in day 1, Tet1kd by shRNA on day 1
(TSKM+Tet1kd 1D) resulted in a consistent increase in 5mC and
a decrease in 5hmC at both Oct4 R-DMRs (Figures 4I and 4J).
Tet1 deficiency also diminished the gain of 5hmC and led to
increased 5mC on both loci during the whole reprogramming
process (Figures 4K and 4L). Furthermore, Tet1 deficiency abol-
ished the demethylation of CpG sites, which were more effi-
ciently demethylated in TSKM+Ctr cells than in OSKM+Ctr
(Figures 4M and 4N). Moreover, when additional Tet1 was
applied in the TSKM system, the 5hmC levels were significantly
increased, and the demethylation of CpG sites was facilitated on
both loci (Figures S4K and S4L).Figure 4. TSKM 2 System Can Initiate Reprogramming Rapidly and E
(A) Schematic of the TSKM 2 system. Fibroblasts were derived from the TSKM m
after 7 day induction and was further used to produce TSKM 2-iPSC mice throu
(B) Kinetics of TSKM 2 induction by FACS at the indicated time points. SSEA1+ ce
at day 7.
(C) Morphology of TSKM 2-iPSC colonies. The original Oct4-GFP+ colonies appe
TSKM 2-iPSC lines could be established (lower panels).
(D) A TSKM 2-iPSC mouse. A full-term TSKM 2-iPSC mouse could be produced
formed.
(E) Tet1 deficiency represses the reactivation of Oct4 in TSKM 2 induction.
(F) Tet1 deficiency represses the reprogramming kinetics of TSKM 2 induction.
(G) CpG dinucleotides of Oct4 R-DMRs undergo demethylation during TSKM 2
(H) Time course of relative 5mC/5hmC enrichment at Oct4 enhancer (left) and pr
(I and J) DNA modification changes at Oct4 enhancer (I) and promoter (J) at indu
content of modified cytosine (right) of different conditions are presented.
(K and L) Tet1 deficiency results in 5mC increase and 5hmC decrease at Oct4 R-
Oct4 enhancer (K) and promoter (L) is shown.
(M and N) TSKM-mediated reprogramming promotes more efficient CpG deme
thylation on Oct4 enhancer (M) and promoter (N) in TSKM 2 induction is represe
(O and P) Occupancy of histone markers and relative enrichment of 5mC/5hmC a
in TSKM 2 induction.
(Q) The relative expression level of Oct4 at day 3 in TSKM 2 induction.
The analyses in the TSKM 2 systemwere performed in parallel to those in the OSK
(n = 3). Data in (M) and (N) are represented as the mean ± SEM (n = 1016). *p
See also Figure S4.ChIP analysis on cells at induction day 3 revealed that Tet1
deficiency led to significantly higher 5mC levels and H3K27me3
occupancy relative to TSKM+Ctr at the two loci (Figures 4O
and 4P). Although Tet1 deficiency also affected 5hmC and
active histone marks, these effects were not as obvious as the
changes observed on the repressive marks. qRT-PCR analysis
revealed that expression of endogenous Oct4 was repressed
by Tet1kd on day 3 relative to controls (Figure 4Q).
These results suggest that Oct4 reactivation depends on Tet1
and 5hmC conversion in the TSKM 2 system. Thus, it seems
that Tet1 can reactivate endogenous Oct4 during reprogram-
ming without a requirement for exogenous Oct4.
An Intermediate Reprogramming Stage in the TSKM 2
System Is Characterized by an Apparent Transcriptional
Transition
We achieved successful reprogramming within one week using
the TSKM 2 system, suggesting that changes occur rapidly at
both the transcriptional and epigenetic levels (Figure 5A). We
realized that for gaining insight into the molecular mechanism
of TSKM-mediated reprogramming it would be important to
identify a distinct intermediate stage where changes are evident.
To this end, we examined the expression level of pluripotency
markers in three groups of cells sorted by FACS, which included
SSEA1+ cells (S+) and two groups of SSEA1 cells (R2 and R7),
from day 3 to day 7 during TSKM 2 reprogramming. We found
that the gene-expression levels among the three groups of cells
were comparable at day 3 (TSKM 3D), but obvious diversity ap-
peared from day 5 (TSKM 5D; Figures S5A and S5B). Therefore,
the TSKM 3D cells seemed to be a relatively homogeneous state
that could be utilized for high-throughput analysis. We per-
formed 5hmC dot blot assays and found a sharp increase in
5hmC on day 3 (Figure S5C). Therefore, we concluded that
TSKM 3D cells constitute an identifiable intermediate stage
that could be used to explore the molecular mechanism of
TSKM-mediated reprogramming.fficiently
ice (E19.5) and induced by Dox. The TSKM 2-iPSC line could be established
gh tetraploid complementation.
lls emerged at day 3, and SSEA1 andOct4-GFP double-positive cells emerged
ared since induction day 7 (upper panels). After withdrawal of Dox for 4 days,
through tetraploid complementation and was alive when C-section was per-
FACS was performed to determine the percentage of Oct4-GFP+ cells.
induction.
omoter (right) in TSKM 2 induction.
ction day 1 in the TSKM 2 system. Relative 5mC/5hmC enrichment (left) and
DMRs in TSKM 2 induction. Time course of relative 5mC/5hmC enrichment at
thylation on Oct4 R-DMRs as compared to OSKM 2 induction. CpG deme-
nted by the time course of 5hmC+5mC content on CGs as indicated.
tOct4 enhancer (O) and promoter (P) at induction day 3 in cultures as indicated
M 2 system. Data in (B), (E)–(L), and (O)–(Q) are represented as the mean ± SD
< 0.05; **p < 0.01; ***p < 0.001 by ANOVA or Student’s t test for comparison.
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Figure 5. The Transcriptome Transition and DNA Modification Dynamics in the TSKM 2 System
(A) Strategy for molecular analysis of TSKM 2 reprogramming. Microarray, MeDIP-seq, and hMeDIP-seq were used for systemic analysis of molecular events in
the TSKM 2 system from fibroblasts to iPSCs.
(B) Clustering of gene-expression profiles based on transcriptional dynamic during TSKM 2 reprogramming. The genes were clustered into five groups (I–V),
according to the expression correlation using k-means algorithms. Each row is a gene (representative genes are listed in the right panel), and each column
represents a sample with repeats. The gene-expression intensity was scaled across samples (red for high expression and green for low expression).
(C) The unique 5mC and 5hmC dynamics during TSKM 2 reprogramming. Quantification of the total 5mC and 5hmC in each cell sample was performed by LC-
MS/MS analysis and normalized to that in R1 ESCs. Data are represented as the mean ± SD (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001 by ANOVA for comparison to
TSKM 0D.
(legend continued on next page)
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Tet1 Can Replace Oct4 in Somatic ReprogrammingWe then performed a microarray analysis using the starting
fibroblasts (TSKM 0D cells), intermediate stage cells (TSKM 3D
cells) and fully reprogrammed iPSCs (TSKM 2-iPSCs; Figure 5A).
As expected, we observed an obvious transcriptional transition
from a somatic to a pluripotent state during TSKM-mediated re-
programming. The gene-expression profiles of TSKM 3D cells
clearly represented an intermediate stage of this transition with
widespread changes (Figure S5D). Importantly, similar transcrip-
tional transitions were observed in OSKM-mediated reprogram-
ming when pre-iPSCs were used as the intermediate-stage cells
(Mikkelsen et al., 2008) (Figure S5D).
Based on the gene-expression dynamics, we clustered the
significantly changed genes into five groups (2,508 genes in
total), representing the major transcriptional events in TSKM-
mediated reprogramming (Figure 5B). A large set of genes (clus-
ters I, II, and III), including many lineage-specific genes, are
repressed in iPSCs. The reported mesenchymal-related genes
(Samavarchi-Tehrani et al., 2010), such as Snail1, Snail2, Zeb1,
Zeb2, and the fibroblast markers Cdh2 and Thy1, were included
(clusters I and II). In contrast, some pluripotency-related genes,
including the key pluripotency factors Oct4, Nanog, Sox2,
Dppa4, and Zfp42, and some reported epithelial genes, such
as Epcam and Cdh1, were reactivated and highly expressed in
TSKM 2-iPSCs (clusters IV and V; Figure 5B).
During epigenetic reprogramming in PGCs, the high expres-
sion of Tet1 and Tet2 and the repression of DNA-methylation-
related genes (Dnmt3a,Dnmt3b,Dnmt3l, andUhrf1) are believed
to account for the 5hmC conversion and passive 5mC depletion
(Hackett et al., 2013; Vincent et al., 2013). Interestingly, we found
that not only Tet1 and Tet2 but also DNA-methylation-related
genes were upregulated during TSKM reprogramming (Figures
5B and S5E). Therefore, a unique mechanism might be em-
ployed to reset an ESC-like DNA modification landscape during
iPSC generation, and this process may further contribute to the
genome-wide epigenetic reprogramming and transcriptional
transition to ensure the attainment of pluripotency.
DNA Modification toward an ESC-like State Is
Characterized by an Increase in 5mC and 5hmC at the
Intermediate Stage
To examine the dynamic changes of 5mC and 5hmC in the TSKM
2 system, we performedmass spectrometry to quantify the total
amount of 5mC and 5hmC modifications during TSKM 2 induc-
tion (Figures 5C and S5F). In TSKM 0D cells, the total amount of
5hmCwas very low (approximately 3% of that in ESCs), whereas
the 5mC content was approximately 20% higher than that in
ESCs. Mass-spectrometry analysis further revealed that 5hmC
showed a consistent increase during TSKM 2 induction (Figure
5C). In contrast, 5mC increased in TSKM cells at days 3 and 5,
and depletion of 5mC appeared to occur much later (Figure 5C).
Immunofluorescent staining of cells from TSKM 0D to TSKM 5D
also indicated that the increase in 5mC and 5hmC could be de-(D) The relative enrichment of 5mC (upper panel) and 5hmC (lower panel) in differe
gene TSS.
(E) The comparison of 5hmCand 5mCmodifications in TSS regions during TSKM2
samples; e.g., TSKM 3D versus 0D is the log ratio of 5mC/5hmC reads in TSKM 3
the log ratio in 5mC-TSKM 3D versus 0D. The color indicates a trend of increase
See also Figures S5 and S7 and Table S1.tected at the same time in cells on day 3 and in clustered cells on
day 5 (Figure S5G).
We then performed MeDIP and hMeDIP sequencing (MeDIP-
seq and hMeDIP-seq) using TSKM 0D and TSKM 3D cells and
TSKM 2-iPSCs (Figure 5A) and used that to generate a DNA
methylation-hydroxymethylation-state map of TSKM-mediated
reprogramming. Consistent with the mass-spectrometry anal-
ysis, we found that the predicted 5mC hot-spot regions first
increased from TSKM 0D to TSKM 3D and decreased in TSKM
2-iPSC (104,011; 165,869; and 61,171, respectively). In addition,
the predicted 5hmC hot-spot regions increased from TSKM 0D
to TSKM 3D and then to TSKM 2-iPSC (42,301; 116,087; and
174,079, respectively; Table S1). We have summarized the rela-
tive enrichment of 5mC and 5hmC modifications at the different
genomic regions. We also noticed that the changes in 5mC and
5hmC did not simply occur over the whole genome but instead
increased at the CpG islands (CGIs) and gene-related regions
(promoters, 50 UTRs, 30 UTRs, and exons; Figure 5D).
We further explored the 5mC and 5hmC changes on transcrip-
tion start site (TSS) regions (2 kb around the TSS) for each indi-
vidual gene. When the genes were ranked according to the
fold changes of 5mC from TSKM 0D to TSKM 3D, a similar
pattern of gradual color change between 5mC and 5hmC sug-
gested that most TSS regions showed an increase in both
5mC and 5hmC during the early stage of reprogramming (from
TSKM 0D to TSKM 3D) (Figure 5E). We observed a general
decrease in 5mC later in the reprogramming process, whereas
the 5hmC enrichment pattern underwent further significant
changes (Figure 5E). Consistent with the increase of 5hmC on
some loci, Tet1, Tet2, and Tet1-activity regulators (Idh1 and
Idh2) were upregulated during the TSKM reprogramming
(Figures S7A and S7B).
The highly coordinated dynamics of 5mC and 5hmC indicated
a genome-wide 5mC-to-5hmC conversion in TSKM-mediated
reprogramming. This type of genome-wide 5hmC conversion
from 5mC could potentially account for the de novo gain of
5hmC early in the reprogramming process and the 5mC deple-
tion at later stages.
The Transcriptional Transition May Be Regulated by the
Dynamic Change of DNA Modification
As a repressive mark, 5mC is believed to have a significant
impact on transcription. We therefore compared the 5mC and
5hmC enrichments on the TSS regions in different gene clusters
to investigate the impact of DNA modification dynamics on tran-
scription during reprogramming. We found that most of the
genes silenced in iPSCs (clusters I, II, and III) are not associated
with significant 5mC increases in TSKM 2-iPSC relative to TSKM
0D (green versus blue lines in Figure S6A). However, we did
observe an increase in 5mC and 5hmC at TSKM 3D (red lines
in Figure S6A). In addition, the genes in cluster I that are strongly
repressed in TSKM 3D cells possess the highest 5mCnt genomic regions. Promoters are defined as1 to +0.5 kb regions around the
 reprogramming. The reads in the gene TSS region were compared among the
D divided by the reads in TSKM 0D. The genes were ordered by the strength of
d enrichment (red) or decreased enrichment (blue) between the two samples.
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whereas the genes in cluster III that have the highest level of
5hmC levels and the lowest 5mC levels expressed highly in
TSKM 3D cells (Figure 6A).
Among the genes activated by reprogramming (clusters IV and
V), demethylation was observed in TSKM 2-iPSC relative to
TSKM 0D (green versus blue lines in Figure S6B). Similarly, the
genes in cluster IV, which were apparently upregulated in
TSKM 3D, contain relatively low 5mC and high 5hmC enrichment
in TSKM 3D cells (Figure 6B).
These results suggest that during TSKM-mediated reprog-
ramming the repressive mark seen at most iPSC-silenced genes
might be established through an increase in 5mC during the
induction process. Moreover, at an intermediate stage of
TSKM reprogramming, the expression status of genes might
be regulated by the DNA modification state around the TSS,
with 5mC acting to silence gene expression and 5hmC having
converse activity.
5hmCConversion Is Important forDNADemethylation of
Both Pluripotency Genes and ESC-Active Regulatory
Regions during Reprogramming
Demethylation of pluripotency genes during reprogramming is
considered to be extremely important for iPSC formation. Our
data indicated that the genes in clusters IV and V undergo deme-
thylation to reach stable transcriptional activity in iPSCs (Fig-
ure S6B). To investigate whether demethylation of key pluripo-
tency genes occurs in a Tet1- and 5hmC-mediated manner
similar to that seen for Oct4, we looked for demethylation-reac-
tivated genes that are significantly upregulated with apparent
demethylation during TSKM-mediated reprogramming and
identified several important pluripotency genes, including
Oct4, Nanog, Gdf3, Zfp42 (Rex1), and Dppa4 (Figures S6C and
S6D).
We further analyzed the expression dynamics of these genes
in TSKM-mediated reprogramming and found that reactivation
of these genes was repressed by Tet1 deficiency and facilitated
by additional Tet1 expression (Figures 6E and S6E). These
dynamics were similar to that seen for Oct4 (Figures 4E and
S4I). We generated 5mC and 5hmC profiles for these genes
calculated at the demethylated loci (Figures 6C and 6D) and
found that the decrease in 5mC was coupled with 5hmC conver-
sion from 5mC, which peaked in either TSKM 3D or TSKM 2-
iPSCs at these loci (Figures 6C and 6D). hMeDIP-qPCR analysis
further revealed that the 5hmC enrichment on these genes in
TSKM 3D cells could be regulated by the Tet1 expression level
(Figure S6F). Therefore, 5hmC conversion from 5mC may be
involved in the demethylation and reactivation of these pluripo-
tency factors during TSKM reprogramming as well. Importantly,
the reactivation of these genes was also affected by the Tet1
expression level in the OSKM 2 system (Figure S6G), which
further suggests that the underlying mechanism for reactivation
of these genes may be shared across different factor-induced
reprogramming systems.
In addition to regulating the expression of pluripotency genes,
epigenetic modification of other regulatory regions may also be
important for establishing pluripotency. We selected two defined
ESC-active regulatory regions: ESC low-methylated regions
(LMRs) and ESC H3K4me3 regions. The LMRs, with an average464 Cell Stem Cell 12, 453–469, April 4, 2013 ª2013 Elsevier Inc.methylation of 30%, represent CpG-poor, distal regulatory
regions, as evidenced by location, DNase I hypersensitivity,
and the presence of enhancer marks and enhancer activities
(Stadler et al., 2011). The H3K4me3 modification is usually asso-
ciated with active regulatory regions and can also be used to
predict active promoters (Heintzman et al., 2007). Consistent
with previous studies (Stadler et al., 2011; Yu et al., 2012), these
regions appeared to have relatively low levels of 5mCenrichment
and higher 5hmC levels than neighboring regions in ESCs (Fig-
ure S6H). The average profile of 5mC and 5hmC showed that
ESC-defined LMRs and H3K4me3 regions were highly enriched
for 5mC in TSKM 0D cells, whereas the 5hmC level was low (Fig-
ure 6F). During TSKM-mediated reprogramming, the 5mC and
5hmC distributions were driven to an ESC-like state via both de-
methylation and relative 5hmC enrichment at the center of these
regions. The accompanying increase in 5mC and 5hmC was
observed in these centers from TSKM0D to TSKM3D, and local-
ization-related DNA demethylation was observed from TSKM 3D
to TSKM 2-iPSCs (Figure 6F). Overall, the data suggest that at
these ESC-active regulatory regions, 5hmC converted from
5mCmight be important for achieving demethylation and obtain-
ing an ESC-like DNAmodification state in iPSCs through TSKM-
mediated reprogramming.
DISCUSSION
In this study, we explored the role of Tet1 and the 5hmC modifi-
cation in iPSC generation. We demonstrated that Tet1 facilitated
conventional iPSC induction. In the OSKM induction system,
Tet1 promoted Oct4 demethylation and reactivation through
5hmC conversion at the Oct4 R-DMRs. Moreover, we discov-
ered that Tet1 could replace Oct4 to initiate somatic cell reprog-
ramming and generate fully pluripotent iPSCs in conjunction with
SKM. Based on that, we established a rapid and efficient TSKM
2 reprogramming system. We showed that the demethylation
and reactivation of endogenousOct4 is Tet1- and 5hmC-depen-
dent in the TSKM reprogramming system. Using mass spec-
trometry and hMeDIP-seq analysis, we generated a unique state
map of 5mC and 5hmC in TSKM-mediated reprogramming,
which is characterized by an increase in both 5mC and 5hmC
at an intermediate stage. Genome-wide analysis of transcrip-
tome and DNA modifications revealed that both DNA methyla-
tion and hydroxymethylation play important roles in transcrip-
tome resetting during reprogramming. Moreover, the
conversion of 5mC to 5hmCmay be important for DNA demethy-
lation of both pluripotency genes and ESC-active regulatory
regions in TSKM-mediated reprogramming.
One major contribution of the present study is that we
successfully established a TSKM 2 reprogramming system
and used it to identify an intermediate reprogramming stage
(TSKM 3D) with relatively homogeneous cells, a clear-cut tran-
scriptional transition, and an apparent 5hmC increase, which
we then used to dissect molecular events in reprogramming at
transcriptional and epigenetic levels. We generated state maps
of transcriptome and DNA methylation and hydroxymethylation;
these maps revealed a two-phase dynamic process during
TSKM-mediated reprogramming (Figure 7A). Phase I (TSKM
0D to TSKM 3D) mainly involved disruption of the somatic epige-
netic landscape. During this phase, an increase in both 5mC and
Figure 6. Reactivation of Pluripotency Genes and ESC-Active Regulatory Regions in TSKM 2 Reprogramming
(A and B) Transcriptional dynamics are related to the DNA modification state at the intermediate stage of TSKM 2 reprogramming. The average expression
intensity for the genes in each cluster (Figure 5B) was displayed, and the average normalized 5mC and 5hmC reads in the gene TSS region were calculated,
respectively. The counts’ distributions were plotted (the box drawn by the ‘‘boxplot’’ command in R statistical language indicated the center quartiles of counts)
for genes silenced in iPSCs (A) and for the genes reactivated in iPSCs (B).
(C and D) 5hmC peaks at the demethylation loci on indicated pluripotent genes at either intermediate or final stage in TSKM 2 induction. The pluripotency genes
were demethylation-reactivated genes, as identified in Figure S6C. The demethylation loci are marked (C). Normalized 5mC (upper panels) and 5hmC (lower
panels) counts on these loci are summarized (D).
(E) Tet1 deficiency represses the reactivation of indicated pluripotent genes. Data are represented as the mean ± SD (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001 by
Student’s t test.
(F) The profiles of 5mC and 5hmC modifications in ESC-LMRs (left panels), ESC-H3K4me3 (middle panels), and ESC-H3K27me3 (right panels, represented as
control) in TSKM 2 induction. The histone-modification-enriched regions are from the unpublished data set, which will be submitted soon (G. Chang and S.G.,
unpublished data). The identification of LMRs was from published data (Stadler et al., 2011).
See also Figure S6.
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Figure 7. A Schematic Model of TSKM-Mediated Reprogramming and Quantification of 5mC and 5hmC in iPSCs
(A) The transcriptional transition and cell morphological changes are coupled with the DNA modification dynamics in TSKM 2 reprogramming.
(B and C) Quantification of genomic 5mC and 5hmC in indicated iPSCs. LC-MS/MS analysis of 5mC (B) and 5hmC (C) were performed with genomic DNA
extracted fromR1 ESCs, TSKM iPSCs, OSKM iPSCs, and 4F-Tet1kd-a# and -b# iPSCs. The valueswere normalized and compared to those in R1 ESCs. Data are
shown as the mean ± SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 by ANOVA for comparison to TSKM 0D.
See also Figure S7.
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5hmC conversion. Moreover, the correlation between 5mC,
5hmC, and the transcriptional state at this stage suggests that
genome-wide DNA methylation and hydroxymethylation
dynamics may contribute to the transcriptional transition in
TSKM-mediated reprogramming (Figures 5B, 5E, 6A, and
S6A). Phase II (TSKM 3D to TSKM 2-iPSC) is characterized by466 Cell Stem Cell 12, 453–469, April 4, 2013 ª2013 Elsevier Inc.the re-establishment of an ESC-like epigenetic landscape. In
this phase, widespread DNA demethylation, especially at the
pluripotency genes and ESC-active regulatory regions, is
accompanied by enrichment of 5hmC, which peaks at either
the intermediate or at the final stage of reprogramming depend-
ing on the particular location (Figures 6C, 6D, 6F, S6B, and S6C).
Our analysis therefore complements other recent studies looking
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Tet1 Can Replace Oct4 in Somatic Reprogrammingat the different stages that occur during the reprogramming
process (Buganim et al., 2012; Golipour et al., 2012; Hansson
et al., 2012; Polo et al., 2012) by focusing on the epigenetic reor-
ganization events involved.
As reported previously, DNA demethylation involving 5hmC
conversion plays important roles in epigenetic reprogramming
in zygotes and PGC specification (Gu et al., 2011; Hackett et al.,
2013; Inoue and Zhang, 2011; Iqbal et al., 2011). The dynamic
changes of 5mC and 5hmC during somatic cell reprogramming
appear distinct from those observed in zygotes and PGCs.
We noticed that expression of the enzymes responsible for de
novo andmaintenance DNAmethylation was upregulated during
iPSC induction (Figures 5B and S5E), and these enzymes could
in principle hinder 5mC depletion during the later stage of re-
programming (from TSKM 5D to TSKM 2-iPSC). However, the
simultaneous upregulation of active demethylase candidates
(Apobec 2, Apobec 3, Tdg, Parp1, and Mbd4) during TSKM re-
programming (Figure S7B) suggests that active demethylation
through 5hmC might function during later stages of iPSC induc-
tion. Therefore, a unique mechanism might be employed in
TSKM iPSC generation to ensure that an ESC-like DNA methyl-
ation and hydroxylation state could be re-established rather than
genome-wide erasure of both 5mC and 5hmC.
As an important epigenetic mark in iPSCs, 5hmC should be
acquired and reset to an ESC-like state. A very recent report
also proposed the important role of 5hmC in establishment of
pluritotency (Costa et al., 2013). Therefore, the establishment
of 5hmC distribution might be conserved in factor-induced
somatic cell reprogramming. We demonstrate that the increase
of 5hmC also occurred in the OSKM2 system, albeit with some-
what different timing (Figure S7C).
However, we then noted that TSKM iPSCs contain compa-
rable levels of 5mC and 5hmC to those in normal ESCs, whereas
OSKM iPSCs and the 4F-Tet1kd iPSCs have less 5hmC and
more 5mC (Figures 7B and 7C). Aberrant DNA methylation is
observed widely in multiple cancers (Dawson and Kouzarides,
2012), and the loss of Tet1 and 5hmC may correlate with many
types of cancers, and 5hmC loss has been recently identified
as an epigenetic hallmark of melanoma (Ko et al., 2010; Kudo
et al., 2012; Lian et al., 2012; Yang et al., 2013). The ESC-like
levels of 5mC and 5hmC in TSKM iPSCs relative to OSKM iPSCs
might partially account for the low tumor incidence observed in
TSKM mice (Figure S3K). It will be important to investigate
whether the 5hmC content is related to the risk of tumorigenesis
of iPSCs, as this is a key issue for future clinical applications.
In summary, our study provides direct evidence that the DNA
hydroxylase Tet1 promotes reprogramming to pluripotency
and can in fact replace exogenous Oct4 in this process. The
TSKM 2 reprogramming system that we have established will
be a valuable tool for further investigation of the mechanisms
of epigenetic remodeling involved in somatic cell reprogramming
and for developing a systematic understanding of the events
that occur in this exciting process.EXPERIMENTAL PROCEDURES
Tet1 Lentiviral Vector Construction and TSKM iPSC Derivation
Full-length mouse Tet1 (GU079948) was cloned from R1 ESCs and inserted
into the FUW-TET-On vector. Inducible TSKM iPSCs were generated as previ-ously described (Brambrink et al., 2008; Stadtfeld et al., 2008). ESC-like colo-
nies appeared 3 to 5 weeks after induction. The colonies were selected and
propagated after Dox withdrawal.
ChIP
The cells used for the ChIP assay were collected from the same dish or
a parallel dish for FACS, qPCR, hMedIP-qPCR, and bisulfate analysis. ChIP
was performed with the MAGnify kit (Invitrogen) and the following antibodies:
anti-Tet1 (Xu et al., 2011), anti-Tet2 (Santa Cruz Biotechnology), anti-Tet3
(Santa Cruz Biotechnology), anti-dimethyl K4 of H3 (Millipore), anti-trimethyl
K4 of H3 (Abcam), anti-trimethyl K27 of H3 (Millipore), and normal rabbit immu-
noglobulin G (MAGnify, Invitrogen).
hMeDIP-Seq
Genomic DNA was prepared using the QIAGEN DNeasy Blood & Tissue Kit or
QIAGEN AllPrep DNA/RNAMini Kit (treatedwith ribonuclease A). hMeDIP- and
MeDIP-seq were performed as previously described (Ficz et al., 2011) using
anti-5hmC (Active Motif) and anti-5mC (Calbiochem), respectively. Genomic
DNA treated with BfaI digestion was further analyzed via qPCR with the de-
signed primers (Table S2). Sonicated genomic DNA (treated with NEBNext
Master Mix) was used for hMeDIP-seq.
Liquid Chromatography-Mass Spectrometry
Cells undergoing reprogramming from day 0 to day 5 in the TSKM 2 system,
R1 ESCs, and iPSCs from different induction systems were used for the 5mC
and 5hmC quantity analysis. Liquid chromatography-tandemmass spectrom-
etry (LC-MS/MS) analysis was performed for analyzing the quantity of 5mC
and 5hmC in the genomic DNA of different cell samples, as detailed in the
Supplemental Experimental Procedures.
Microarray Analysis
Total RNA was extracted using Trizol reagent (Invitrogen) from starting fibro-
blasts, intermediate-stage reprogrammed cells, and the fully reprogrammed
iPSCs in three separate experiments. Analysis with the Mouse Gene 1.0 ST
array (Affymetrix) was performed at CapitalBio in Beijing.
Mice
All of our study procedures were consistent with the National Institute of
Biological Sciences guide for the care and use of laboratory animals.
Statistics
The Holm-Sidak test (for ANOVA) or Student’s t test was performed using
SigmaStat 3.5 software for statistics comparison.
ACCESSION NUMBERS
The microarray data sets and MeDIP and hMeDIP deep-sequencing data
sets have been deposited in NCBI’s Gene Expression Omnibus (GEO) under
accession number GSE39639.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2013.02.005.
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